Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

30

Revenue 2017

Botox/Neuromodulator

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Botox/Neuromodulator was produced by Allergan.

Teva’s migraine injection approved in Europe

Teva’s migraine injection approved in Europe The FDA also recently accepted an NDA from Botox developer Allergan, which filed its oral CGRP ubrogepant for the acute treatment of migraine in adults.

Depression drug failure adds to Allergan's woes

Depression drug failure adds to Allergan's woes women's health unit and face competitive threats to top sellers such as Botox.

NICE rejects Novartis migraine treatment Aimovig

NICE rejects Novartis migraine treatment Aimovig Botox is normally offered to patients when at least three oral preventative treatments have been tried for those with chronic migraine. ... Despite this, a report by ICER, US pricing watchdog, says Aimovig would only be cost-effective if used after Botox

Teva wins FDA OK for crucial migraine drug

Teva wins FDA OK for crucial migraine drug 900 before rebates and discounts – exactly the same level as Novartis and Amgen positioned Aimovig, and in line with stablished therapies like Allergan’s Botox. ... other preventive options such as Botox and anti-epilepsy drugs like topiramate

CGRP migraine drugs need prior approval for use, recommends ICER

CGRP migraine drugs need prior approval for use, recommends ICER that it offered value for money, but only if other migraine prevention options such as Allergan’s Botox and anti-epilepsy drugs such as topiramate had been exhausted.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...

Latest intelligence

The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...

Infographics